Surgical Innovations Group (SUN)

Sector:

Health Care

Index:

FTSE AIM All-Share

 NULL
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: NULL
  • 52 Week Low: 1.00p
  • Currency: UK Pounds
  • Shares Issued: 932.82m
  • Volume: 0
  • RiskGrade: 341
  • Beta: 0.00

Surgical Innovations warns on profits as Brexit uncertainty takes its toll

By Iain Gilbert

Date: Friday 07 Jun 2019

LONDON (ShareCast) - (Sharecast News) - Surgical solutions group Surgical Innovations warned on profits on Friday as it said the lack of momentum seen in the first quarter has continued into the second.
The company said orders from its UK and EU operations had been lower than expected, with ongoing Brexit uncertainty disrupting order patterns from its distributors and end users, making it more complicated to forecast its outlook for the remainder of the year.

In the UK, the AIM-listed firm saw overall volumes of activity become "a continuing concern" after demand was hindered as a result of lower levels of activity in the NHS.

On the other hand, revenues from its export markets outside the EU remain unaffected, principally in the States where it reported strong growth throughout the quarter.

The group also noted that regulatory approvals had become "increasingly challenging", placing an increased burden on its operational and technical resources.

As a result, Surgical Innovations cautioned that revenue growth in its second half was "unlikely" to fully counter the weakness seen in the first, with adjusted pre-tax profits now expected to be lower year-on-year.

At 0930 BST, Surgical Innovations shares were down 33.06% to 2.74p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

SUN Market Data

Currency UK Pounds
Share Price NULL
Closing Price Change 0.000p
% Change 0.00 %
52 Week High NULL
52 Week Low 1.00p
Volume 0
Shares Issued 932.82m
Beta 0.00
RiskGrade 341

SUN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
50.36% above the market average50.36% above the market average50.36% above the market average50.36% above the market average50.36% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Price Trend
14.25% below the market average14.25% below the market average14.25% below the market average14.25% below the market average14.25% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Income Not Available
Growth
12.13% below the market average12.13% below the market average12.13% below the market average12.13% below the market average12.13% below the market average
54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average54.29% below the sector average

What The Brokers Say

Strong Buy 0
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 1
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SUN Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

SUN Key Personnel

CEO David Marsh
Chair Jonathan Glenn

Top of Page